Acute viral bronchiolitis phenotype in response to glucocorticoid and bronchodilator treatment
- PMID: 38843677
- PMCID: PMC11215958
- DOI: 10.1016/j.clinsp.2024.100396
Acute viral bronchiolitis phenotype in response to glucocorticoid and bronchodilator treatment
Abstract
Objective: To analyze whether infants admitted to hospital with Acute Viral Bronchiolitis (AVB), who received glucocorticoids and bronchodilators, and who had an atopic phenotype, spent less time in hospital and/or less time on oxygen therapy when compared to those who did not have the phenotype.
Method: A cross-sectional, retrospective epidemiological study was developed with data from medical records of infants admitted to hospital due to AVB from 2012 to 2019 in a sentinel public hospital. It was verified that the frequency of prescription of glucocorticoids, bronchodilators and antibiotics. Length of stay and oxygen therapy duration were then compared in the group that used glucocorticoids and bronchodilators between those who had a personal or family history of atopy and those who did not. Subsequently, the length of hospital stay was compared among infants who received antibiotic therapy and those who did not.
Results: Fifty-eight infants were included. Of these, 62.1 % received an antibiotic, 100 % a bronchodilator and 98.3 % a glucocorticoid. When comparing infants without a family history of atopy, those who received antibiotics had a longer hospital stay (p = 0.01).
Conclusion: The presence of an atopic phenotype did not interfere with the length of stay and/or oxygen therapy duration of those who received bronchodilators and glucocorticoids. Increased length of stay of infants without a family history of atopy, who used antibiotics without evidence of bacterial co-infection, and the high frequency of prescription of non-recommended drugs call attention to stricter protocol implementation and professional training in AVB diagnosis and care.
Keywords: Bronchiolitis; Bronchodilator; Glucocorticoid; Phenotype; Respiratory syncytial virus; Treatment.
Copyright © 2024 HCFMUSP. Published by Elsevier España, S.L.U. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no conflicts of interest.
Figures
References
-
- Ralston S.L., Lieberthal A.S., Meissner H.C., Alverson B.K., Baley J.E., Gadomski A.M., et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatr - American Acad Pediatr. 2014;134(5):1474–1502. - PubMed
-
- Brasil, Ministério da Saúde. Sistema de Informações Hospitalares do SUS (SIH/SUS) [Internet]. DATASUS. 2022 [cited 2022 aug 29]. Available from: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/niuf.def
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources